Skip to main content
. 2014 Jan 27;64(619):e75–e80. doi: 10.3399/bjgp14X677121

Table 3.

Worsening of illness according to subgroup in amoxicillin versus placebo group

Amoxicillin Placebo Interaction terma (95% CI) P-value Odds ratio for subgroupa (95% CI) P-value
Whole cohort 162/1021 194/1006 0.79 (0.63 to 0.99) 0.043
Green sputum 40/221 43/185 0.93 (0.53 to 1.61) 0.787 0.73 (0.45 to 1.18) 0.202
Current smoker 47/304 45/269 1.21 (0.72 to 2.03) 0.482 0.91 (0.58,1.42) 0.680
Significant past historyb 44/257 47/243 1.11 (0.65 to 1.88) 0.692 0.86 (0.55 to 1.36) 0.520
Prior duration of illness >7 days 70/411 74/390 1.16 (0.73 to 1.86) 0.528 0.88 (0.61 to 1.26) 0.474
Fever at baseline 59/345 70/347 1.05 (0.65 to 1.69) 0.844 0.82 (0.56 to 1.20) 0.300
Minor chest signs 57/345 70/334 0.92 (0.57 to 1.49) 0.740 0.75 (0.51 to 1.10) 0.139
a

Estimates controlled for baseline symptom severity.

b

Lung disease, heart disease, diabetes, or hospital admission.